Chinese non-tariff barriers impeding India trade growth: Sitharaman

Finance Minister Nirmala Sitharaman has raised concerns over China's non-tariff trade barriers, citing them as a persistent challenge to strengthening economic ties between the two nations. The barriers are disproportionately affecting Indian exports in critical sectors including generic pharmaceuticals, beef and fresh vegetables, she noted.

Non-tariff barriers—which include regulatory requirements, certification standards and administrative procedures—often prove more restrictive than conventional tariffs in limiting market access. Sitharaman's comments underscore India's frustration with obstacles that go beyond traditional customs duties, making it difficult for Indian exporters to compete in the Chinese market.

The pharmaceutical sector, in which India holds a competitive advantage as a leading generic drug manufacturer, has been particularly impacted by stringent Chinese regulatory approvals and quality standards. Agricultural exports, including beef and vegetables, face similar hurdles stemming from quarantine protocols and certification requirements.

These trade impediments come at a time when both nations have been attempting to stabilize their economic relationship. Addressing structural trade barriers remains essential for any meaningful expansion of bilateral commerce and for fostering broader cooperation between Asia's two largest economies.

India has consistently advocated for reciprocal market access and a reduction in such non-tariff obstacles as part of broader efforts to enhance bilateral trade relations and address the persistent trade imbalance favoring China.